🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/07/2015 | 56,30 | 56,61 | 56,01 | 56,26 | +0,75% | 1,07% | 9.172.620 |
| 30/07/2015 | 55,94 | 56,13 | 55,61 | 55,84 | -0,03% | 0,92% | 7.324.996 |
| 29/07/2015 | 55,05 | 56,13 | 55,00 | 55,86 | +1,77% | 2,05% | 13.494.048 |
| 28/07/2015 | 53,93 | 55,00 | 53,27 | 54,89 | +0,93% | 3,20% | 17.173.681 |
| 27/07/2015 | 54,80 | 54,82 | 54,04 | 54,38 | -0,73% | 1,43% | 15.601.576 |
| 24/07/2015 | 55,07 | 55,23 | 54,69 | 54,78 | -1,14% | 0,97% | 8.223.761 |
| 23/07/2015 | 55,85 | 55,85 | 55,29 | 55,41 | -0,10% | 1,01% | 6.750.797 |
| 22/07/2015 | 55,83 | 56,33 | 55,35 | 55,47 | -0,92% | 1,74% | 9.031.454 |
| 21/07/2015 | 56,29 | 56,32 | 55,96 | 55,98 | -0,56% | 0,63% | 7.265.574 |
| 20/07/2015 | 56,26 | 56,49 | 56,16 | 56,30 | +0,31% | 0,58% | 5.970.666 |
| 17/07/2015 | 56,01 | 56,22 | 55,91 | 56,13 | +0,00% | 0,56% | 7.324.367 |
| 16/07/2015 | 55,83 | 56,17 | 55,68 | 56,13 | +1,03% | 0,89% | 5.580.286 |
| 15/07/2015 | 55,50 | 55,88 | 55,41 | 55,55 | +0,05% | 0,84% | 6.024.533 |
| 14/07/2015 | 55,25 | 55,61 | 55,04 | 55,52 | +0,55% | 1,04% | 7.582.385 |
| 13/07/2015 | 55,58 | 55,87 | 55,04 | 55,22 | -0,14% | 1,49% | 9.572.222 |
| 10/07/2015 | 55,41 | 55,58 | 54,94 | 55,30 | +0,99% | 1,15% | 8.433.675 |
| 09/07/2015 | 55,38 | 55,51 | 54,72 | 54,75 | +0,05% | 1,41% | 9.094.334 |
| 08/07/2015 | 55,09 | 55,10 | 54,50 | 54,72 | -1,10% | 1,07% | 9.548.957 |
| 07/07/2015 | 55,11 | 55,44 | 54,56 | 55,33 | +0,76% | 1,59% | 9.467.946 |
| 06/07/2015 | 54,62 | 55,19 | 54,05 | 54,91 | -0,21% | 2,10% | 8.440.697 |
| 02/07/2015 | 55,29 | 55,66 | 54,87 | 55,03 | +0,12% | 1,43% | 8.927.283 |
| 01/07/2015 | 54,32 | 55,22 | 54,02 | 54,96 | +1,18% | 2,21% | 9.830.345 |
| 30/06/2015 | 55,07 | 55,07 | 54,11 | 54,32 | -0,63% | 1,73% | 12.415.970 |
| 29/06/2015 | 55,28 | 55,55 | 54,63 | 54,67 | -2,05% | 1,67% | 10.062.058 |
| 26/06/2015 | 55,55 | 55,85 | 55,20 | 55,81 | +1,02% | 1,17% | 13.711.718 |
| 25/06/2015 | 55,58 | 55,92 | 55,08 | 55,25 | -0,58% | 1,51% | 10.428.858 |
| 24/06/2015 | 56,22 | 56,33 | 55,57 | 55,57 | -1,34% | 1,34% | 8.288.003 |
| 23/06/2015 | 56,18 | 56,35 | 55,84 | 56,33 | +0,34% | 0,90% | 8.772.808 |
| 22/06/2015 | 56,10 | 56,49 | 55,75 | 56,14 | +1,36% | 1,31% | 8.763.900 |
| 19/06/2015 | 55,73 | 56,15 | 55,30 | 55,38 | -0,94% | 1,52% | 13.218.948 |